Socialist Party deputy Juan Luis Castro has revealed his growing suspicions regarding possible price-fixing between several laboratories across the country, representing much of Chile’s pharmaceutical industry. The congressman has pointed to a 42% increase in the prices of 16 of the country’s 20 most-used medications, all during a short period between 2015 and 2016.
Castro, who is a member of the Health Commission, believes that “this increase in the price of 20 of Chile’s most consumed medications is a low blow to the middle class and all popular sectors, since it implies increases in common remedies such as paracetamol, ibuprofen, loratadine, salbutamol and many other daily-use substances.”
Castro announced his intentions to “take these findings to the Public Health Institute and the National Economic Prosecutor, because there probably are signs of collusion, agreements to raise prices in their products, as has already been seen with drugstores and which may now be occurring between laboratories.”
Full Content: Terra
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Pfizer Settles Remaining Effexor XR Antitrust Claims for $25.5 Million
Apr 29, 2024 by
CPI
South Korean Regulator Approves LG Uplus and Kakao Mobility EV Charging Venture
Apr 29, 2024 by
CPI
Federal Judge Dismisses Doctors’ Antitrust Suit Against Ohio Health System
Apr 29, 2024 by
CPI
Paramount CEO Bob Bakish Steps Down as Merger Inches Closer
Apr 29, 2024 by
CPI
EU Brands Apple’s iPadOS as Gatekeeper in Tech Crackdown
Apr 29, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI